Gut microbiota and intestinal barrier components

The gut microbiota and intestinal barrier components constitute a complex biological system essential for maintaining host health and systemic homeostasis (Nature Reviews Gastroenterology & Hepatology, 2021). The microbiota consists of trillions of microorganisms, including bacteria, fungi, and viruses, which perform critical roles in nutrient metabolism and immune system education (NIH, 2023). The intestinal barrier is a multi-layered defense mechanism comprising a chemical mucus layer and a physical layer of epithelial cells sealed by tight junction proteins like claudins and occludin (StatPearls, 2023). Dysregulation of this system, often characterized by increased intestinal permeability or leaky gut, is a hallmark of diseases such as inflammatory bowel disease (IBD), obesity, and certain autoimmune disorders (PubMed, 2022). Therapeutic interventions targeting this axis include probiotics to restore microbial balance, GLP-2 analogs like Teduglutide to promote mucosal growth, and zonulin inhibitors like Larazotide to stabilize tight junctions (Journal of Clinical Investigation, 2020). Because this is a composite system rather than a single molecule, drug development often focuses on specific microbial metabolites or individual barrier proteins to achieve therapeutic effects.

Other names

Gut microbiomeIntestinal mucosal barrierGut-intestinal axisIntestinal permeability componentsIntestinal epithelial barrier

Drugs targeting this system act by promoting the expression of tight junction proteins, modulating the composition of the commensal microbiota, or neutralizing pro-inflammatory microbial products to restore barrier integrity (Nature, 2021).